moxifloxacin has been researched along with odanacatib in 1 studies
| Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (odanacatib) | Trials (odanacatib) | Recent Studies (post-2010) (odanacatib) |
|---|---|---|---|---|---|
| 3,157 | 552 | 1,690 | 148 | 27 | 128 |
| Protein | Taxonomy | moxifloxacin (IC50) | odanacatib (IC50) |
|---|---|---|---|
| Cathepsin L2 | Homo sapiens (human) | 0.762 | |
| Procathepsin L | Homo sapiens (human) | 3.919 | |
| Cathepsin B | Homo sapiens (human) | 1.3613 | |
| Cathepsin S | Homo sapiens (human) | 0.197 | |
| Cathepsin K | Homo sapiens (human) | 0.0005 | |
| Cathepsin K | Oryctolagus cuniculus (rabbit) | 0.001 | |
| Cathepsin F | Homo sapiens (human) | 0.795 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brandquist, C; Chakravarthy, M; Gutierrez, M; Liu, C; Liu, F; Mahon, C; McCrea, J; Mostoller, K; Panebianco, D; Stoch, SA; Zajic, S | 1 |
1 trial(s) available for moxifloxacin and odanacatib
| Article | Year |
|---|---|
Thorough QTc Evaluation and the Safety of Supratherapeutic Doses of Odanacatib in Healthy Subjects.
Topics: Adult; Biphenyl Compounds; Cathepsin K; Dose-Response Relationship, Drug; Double-Blind Method; Drug Dosage Calculations; Electrocardiography, Ambulatory; Female; Healthy Volunteers; Heart Rate; Humans; Long QT Syndrome; Male; Margins of Excision; Moxifloxacin; Young Adult | 2019 |